THE SURVIVAL RATE OF LC IS 15.5%.
THAT’S UNACCEPTABLE. WE’RE
HERE TO CHANGE THAT.

 

Leading Cancer Hospital Becomes First in India to Offer Stereotactic Lung Radiosurgery Treatments Using Varian’s RapidArc(R) Technology

A 65-year-old man with inoperable lung cancer has become the first lung cancer patient in India to receive stereotactic radiosurgery, a promising new approach for treating this disease.  Doctors at Yashoda Hospital in Hyderabad were able to deliver the treatment using RapidArc technology from Varian Medical Systems (NYSE: VAR).

Several recent studies* have shown that lung cancer responds favorably to radiosurgery, which involves delivering the full dose in as little as one to five treatments. With the Varian RapidArc technology each radiosurgery session could be performed in just ten minutes, including patient setup and imaging, with the actual ‘beam-on’ time being as little as three minutes.

 

Trackback

 

Leave a Reply